scispace - formally typeset
V

Valerie E. Vancollie

Researcher at Wellcome Trust Sanger Institute

Publications -  21
Citations -  776

Valerie E. Vancollie is an academic researcher from Wellcome Trust Sanger Institute. The author has contributed to research in topics: Medicine & Gene. The author has an hindex of 8, co-authored 15 publications receiving 579 citations.

Papers
More filters
Journal ArticleDOI

A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains

TL;DR: Comparison of C57BL/6J and C57bl/6N demonstrates a range of phenotypic differences that have the potential to impact upon penetrance and expressivity of mutational effects in these strains.
Journal ArticleDOI

Mouse screen reveals multiple new genes underlying mouse and human hearing loss.

TL;DR: A genetic approach to identify new molecules involved in hearing loss by screening a large cohort of newly generated mouse mutants using a sensitive electrophysiological test, the auditory brainstem response (ABR), reveals new molecular pathways involved in progressive hearing loss.
Journal ArticleDOI

Mcph1-Deficient Mice Reveal a Role for MCPH1 in Otitis Media

TL;DR: These findings revealed an unexpected phenotype, otitis media with hearing impairment, which suggests Mcph1 is a new gene underlying genetic predisposition to otitisMedia, and recapitulated the defects found in otherMcph1-deficient mice or MCPH1 patients.
Journal ArticleDOI

Novel skin phenotypes revealed by a genome-wide mouse reverse genetic screen

TL;DR: This study analyses skin from 538 knockout mouse mutants generated by the Sanger Institute Mouse Genetics Project to create the first large-scale genome-wide tissue phenotype screen from the International Knockout Mouse Consortium and provides an open access resource for the scientific community.
Journal ArticleDOI

Development and Characterization of a Novel Animal Model of Intermittent MDMA (“Ecstasy”) Exposure during Adolescence

TL;DR: A rat model of intermittent adolescent MDMA exposure that simulates many of the features of human weekend use is developed and characterized and adolescent MDMA‐treated animals are protected against the neurotoxic and depressant effects of a subsequent MDMA “binge” challenge.